Therapy News and Research

RSS

COVID-19 vaccine-induced immunity in heart and kidney solid organ transplant recipients

The present study entailed assessments of both infected and uninfected SOTRs against the D614G-CoV2 baseline virus and eight other variants.

17 Feb 2022

Skin cells outside of the hair follicles play large role in the development of a pimple

Acne is among the most common skin diseases in the United States, according to the American Academy of Dermatology Association, affecting up to 50 million Americans each year. It is also among the least studied.

17 Feb 2022

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease

From Illumina, Inc. 17 Feb 2022

Search for a treatment to stop nerve cell degeneration yields promising results

Researchers at the University of Illinois Chicago found promising results in their search for a treatment to stop nerve cell degeneration that happens in some types of disorders, such as hereditary spastic paraplegia and Parkinson's disease, which can cause significant disability.

17 Feb 2022

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Researchers developed a novel computational model to predict the binding affinity between the hACE2 receptor and the RBD of S protein of SARS-CoV-2.

17 Feb 2022

Study investigates what causes blood malignancies linked to gene therapy for sickle cell disease

Gene therapy trials for sickle cell disease have been showing great promise, even offering hope of a cure. But in early 2021, the trials ground to a halt after reports of blood malignancies in two people in a trial sponsored by bluebird bio.

16 Feb 2022

UVMCC researchers address new paradigms in rectal cancer multidisciplinary care

In recent years total neoadjuvant treatment (TNT) - a potent new treatment approach for advanced colorectal cancer that confronts tumors with aggressive rounds of chemotherapy and chemoradiation followed by surgery to remove the cancerous tissue - has emerged as the standard of care.

16 Feb 2022

Risk factors for COVID-19 in older adult patients with cancer

Researchers develop a geriatric risk score to predict the risk of severe clinical outcomes in older cancer patients with COVID-19.

16 Feb 2022

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10%

As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other side-effects.

16 Feb 2022

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

A new study discusses the state of current knowledge about the potential use of tea polyphenols in the prevention and treatment of COVID-19.

16 Feb 2022

New project aims to improve the lives of stroke survivors with aphasia

A Queensland researcher will lead a new project aimed at improving the lives of people with aphasia, a debilitating condition that impacts one in three survivors of stroke.

15 Feb 2022

Use of immunosuppressants for inflammatory rheumatic diseases and the associated risk of severe COVID-19

A recent study posted to the medRxiv* preprint server investigated the risk of severe/fatal coronavirus disease 2019 (COVID-19) in patients treated with immunosuppressants for inflammatory rheumatic diseases (IRD).

15 Feb 2022

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Virginia Commonwealth University will radically expand treatment options for liver and liver-related metabolic diseases thanks to a historic, transformational $104 million gift from Richard Todd Stravitz, M.D., and his family's Barbara Brunckhorst Foundation.

15 Feb 2022

Two doses of psilocybin may ease depression symptoms for up to 12 months

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month.

15 Feb 2022

Canadian study estimates incidence rate of reinfection in healthcare workers

Researchers from various Canadian institutions document all cases of reinfection discovered during the first year of the project.

15 Feb 2022

Researchers create a comprehensive atlas of cerebrovascular cell types

While neurons and glial cells are by far the most numerous cells in the brain, many other types of cells play important roles. Among those are cerebrovascular cells, which form the blood vessels that deliver oxygen and other nutrients to the brain.

15 Feb 2022

Novel promising biomarker correlates with the severity of facioscapulohumeral muscular dystrophy

There is currently no effective treatment for facioscapulohumeral muscular dystrophy (FSHD), one of the most common neuromuscular diseases, which is caused by an abnormal expression of the transcription factor DUX4.

15 Feb 2022

Researchers find potential new strategy to treat metastatic form of intra-abdominal cancer

Researchers from the National Cancer Centre Singapore (NCCS) have found a potential new strategy to treat peritoneal carcinomatosis, a metastatic form of intra-abdominal cancer, where patients are presented with limited treatment options and poor overall survival.

15 Feb 2022

Older woman's estrogen levels may be linked to risk of COVID-19 death

An older woman's estrogen levels may be linked to her chances of dying from COVID-19, with higher levels of the hormone seemingly protective against severe infection, suggests research published in the open access journal BMJ Open.

15 Feb 2022

Study finds increased risk of psychosis in illicit amphetamine users

The illicit use of amphetamines, the stimulants commonly known as 'speed', is linked to a 5-fold heightened risk of psychosis, finds a 10 year study published online in the journal Evidence-Based Mental Health.

15 Feb 2022

Therapy News and Research

COVID-19 vaccine-induced immunity in heart and kidney solid organ transplant recipients

Skin cells outside of the hair follicles play large role in the development of a pimple

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Search for a treatment to stop nerve cell degeneration yields promising results

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Study investigates what causes blood malignancies linked to gene therapy for sickle cell disease

UVMCC researchers address new paradigms in rectal cancer multidisciplinary care

Risk factors for COVID-19 in older adult patients with cancer

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10%

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

New project aims to improve the lives of stroke survivors with aphasia

Use of immunosuppressants for inflammatory rheumatic diseases and the associated risk of severe COVID-19

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Two doses of psilocybin may ease depression symptoms for up to 12 months

Canadian study estimates incidence rate of reinfection in healthcare workers

Researchers create a comprehensive atlas of cerebrovascular cell types

Novel promising biomarker correlates with the severity of facioscapulohumeral muscular dystrophy

Researchers find potential new strategy to treat metastatic form of intra-abdominal cancer

Older woman's estrogen levels may be linked to risk of COVID-19 death

Study finds increased risk of psychosis in illicit amphetamine users

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News